PillPack targets a specific sector of patients who have to take several different medications at any time. It packages pills in individual packets that help people remember when to take their drugs every day, an issue faced by many people taking, for example, drugs for diabetes, high cholesterol, blood pressures and cancer.
Buying PillPack is not Amazon’s first move into healthcare. It already sells over-the-counter medicines such as aspirin and antihistamines here in America, in addition to vitamins, supplements, and other health-related products. It even launched its own line of off-brand medicines called Basic Care in mid-2017 which sells medical supplies such as face masks and swabs and plans to expand into supplying hospitals and clinics with them as well.
Those who are watching the move closely anticipate that Amazon will eventually drive drug prices down due to its almost monopoly-like control over the delivered goods industry.
According to results from the 2018 Walker Sands Future of Retail report, 29% of consumers say they’re excited about the convenient experience Amazon provides, and that they’re already used to using it to make purchases.
Some 61% of respondents say they want to order prescriptions from Amazon because of its ability to ship quickly, and 54% said they would do so because of their existing trust in it and ensuring that their medicine was safe, accurate, cost-effective and easy to ingest.
They’d also want to know that their questions about the medicine were easily answered as they would be if they picked them up in person from a pharmacy technician at a drugstore for instance.
For patients with chronic conditions, as many as 50% don’t take their prescribed medications because of high costs, she says, and as many as 20% to 30% of prescriptions are never filled. With Amazon and PillPack, the pesky action traveling to and waiting in line at the pharmacy will be eliminated and hopefully help individuals get the medicine they desperately need and overcome past barriers.
There’s also the prospect of threading through Amazon’s same-day distribution into pharmaceutical deliveries. There could also be the utilization of telemedicine.
However, much of this speculation about the future will take quite some time to implement, we’re sure.
Amazon’s acquisition could have other long-term implications for traditional care providers, byadding another factor that can provide care management capabilities—offering a technological link that can ensure patients get the right treatment at the right time from the comfort of their own familiar environment i.e. their homes.
There’s also the prospect of threading through Amazon’s same-day distribution into pharmaceutical deliveries.
But, as exciting as these possibilities may sound, Amazon is in the early of the deal and will be figuring out logistics as the time passes. We’ll keep an eye on this exciting venture.
Jasmine Browley holds an MA in journalism from Columbia College Chicago, and has contributed to Ebony, Jet and MADE Magazine among others. So, clearly, she knows some stuff. Follow her digital journey @JasmineBrowley.